By: Sabrina Serani From: targetedonc.com Breast cancer remains a significant health challenge worldwide. Despite advancements in treatment, many women continue to face its devastating impact. In an interview with Targeted OncologyTM, Oranus Mohammadi, MD, medical oncologist at The Oncology Institute of Hope & Innovation, discussed the remarkable progress made in improving survival rates for patients with breast cancer. She delved …
Confronting Challenges and Embracing Progress in HER2+ Breast Cancer
By: Yara Abdou, MD From: targetedonc.com Yara Abdou, MD, medical oncologist at the University of North Carolina (UNC) in Chapel Hill, looks back on what have been the biggest challenges in treating HER2-positive breast cancer over the past 5-10 years. While HER2-positive breast cancer has previously shown high mortality rates, the emergence of targeted therapies including trastuzumab (Herceptin), pertuzumab (Perjeta), …
Progress in Treating Brain Metastases in Breast Cancer Puts Multidisciplinary Approaches Into Focus
By: Chris Ryan From: onclive.com Brain metastases are a common complication in patients with breast cancer, and although systemic therapies for patients with HER2-positive disease have displayed promise in penetration of the blood-brain barrier, work remains for subsets of patients with central nervous system (CNS) metastases, according to Barbara O’Brien, MD.1 “For most patients, the treatment [for brain metastases has …
Study Shows Progress in Breast Cancer Survivorship Over 15 Years
By: Jill Murphy From: pharmacytimes.com Over a 15-year span from 2007 to 2021, there were 370,756 patients diagnosed with breast cancer in Canada, of whom 86% would have survived by 2022, according to a study recently published in the Journal of the National Comprehensive Cancer Network. “This indicates that the prevalence of breast cancer survivors in the Canadian female population has doubled …
Year in Review: Panelists summarize key findings in breast cancer research in 2021
From: sabcsmeetingnews.org Despite the ongoing challenges of COVID-19 over the past year, researchers in 2021 reported important progress and major discoveries in breast cancer. A panel of experts discussed some of the latest advances in early and advanced breast cancer, basic science, and translational research during the special session Year in Review on Friday, December 10 at SABCS 2021. Basic …
Hope, progress at annual breast cancer symposium
By: Virginia Kaklamani and Ruben Mesa, For the Express-News From: mysanantonio.com This is the 40th anniversary of the San Antonio Breast Cancer Symposium, which starts today at the Convention Center. As the 2017 symposium begins, we reflect on this important meeting’s value to patients and families everywhere. When the symposium began in 1978, women with breast cancer faced a far …